CVS Health (NYSE:CVS) Releases FY 2026 Earnings Guidance

CVS Health (NYSE:CVS) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 5.940-6.140 for the period, compared to the consensus earnings per share estimate of 7.160. The company issued revenue guidance of -.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Wolfe Research boosted their price target on CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, December 8th. Leerink Partners boosted their target price on CVS Health from $86.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, October 16th. Evercore raised their price target on shares of CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. Wells Fargo & Company reduced their target price on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a report on Thursday, November 13th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a report on Monday, December 29th. Nineteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.82.

CVS Health Stock Performance

NYSE CVS traded up $2.06 on Tuesday, reaching $77.83. The stock had a trading volume of 3,824,552 shares, compared to its average volume of 9,764,484. CVS Health has a 1-year low of $54.06 and a 1-year high of $85.15. The company has a market cap of $98.80 billion, a P/E ratio of 204.33, a price-to-earnings-growth ratio of 0.72 and a beta of 0.50. The firm has a fifty day moving average of $78.56 and a two-hundred day moving average of $75.87. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63.

CVS Health (NYSE:CVS) last announced its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.99 by $0.10. The firm had revenue of $105.69 billion for the quarter, compared to analyst estimates of $103.67 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business’s revenue was up 8.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, equities research analysts anticipate that CVS Health will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were given a $0.665 dividend. The ex-dividend date was Thursday, January 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. CVS Health’s payout ratio is presently 700.00%.

Key Headlines Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Q4 beat on both EPS and revenue: CVS reported adjusted EPS of $1.09 versus a $0.99 consensus and revenue of $105.7B, driven by higher prescription volume. CVS Health (CVS) Tops Q4 Earnings and Revenue Estimates
• Positive Sentiment: PBM and retail pharmacy strength: Reuters and other outlets cite pharmacy benefit management performance and strong retail script volumes as the main drivers of the beat. That supports operating recovery momentum. CVS Health beats quarterly profit expectations on pharmacy performance
• Positive Sentiment: Operational progress: Management completed a transition to cost‑based reimbursement across payors and highlighted Aetna prior‑authorization improvements, evidence the turnaround plan is executing. CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
• Neutral Sentiment: Company narrative mixed on guidance: several outlets note CVS “reaffirmed” its profit outlook/strategy progress, which soothes some investors but doesn’t fully offset other concerns. CVS tops quarterly estimates, reaffirms profit outlook as turnaround plan takes effect
• Negative Sentiment: FY‑2026 EPS range disappointed some investors: CVS set FY26 adjusted EPS guidance around 5.94–6.14, below some street expectations, creating a forward-earnings shortfall that is pressuring the stock. CVS Health drops despite Q4 beat amid in-line guidance
• Negative Sentiment: Cash‑flow/guidance nudges: reports indicate cash‑flow guidance was lowered or softened, which reduces near-term financial flexibility and heightened investor caution. CVS Health beats Q4 expectations, cash flow guidance lowered
• Negative Sentiment: Medicare policy risk: commentary from Barron’s and others highlights concern that proposed Medicare rate changes could pressure pharmacy/insurance margins, an overhang leading some investors to trim positions. CVS Stock Falls After Earnings Beat. Why Medicare Worries Persist.

Institutional Trading of CVS Health

A number of hedge funds have recently added to or reduced their stakes in the stock. Caitong International Asset Management Co. Ltd grew its holdings in CVS Health by 407.2% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 281 shares during the period. Mpwm Advisory Solutions LLC grew its position in CVS Health by 40.0% in the 3rd quarter. Mpwm Advisory Solutions LLC now owns 700 shares of the pharmacy operator’s stock valued at $53,000 after purchasing an additional 200 shares during the period. WFA of San Diego LLC bought a new stake in shares of CVS Health during the second quarter worth about $86,000. Sittner & Nelson LLC lifted its position in CVS Health by 164.7% in the 3rd quarter. Sittner & Nelson LLC now owns 1,607 shares of the pharmacy operator’s stock valued at $121,000 after acquiring an additional 1,000 shares in the last quarter. Finally, Johnson Financial Group Inc. boosted its position in shares of CVS Health by 94.9% during the third quarter. Johnson Financial Group Inc. now owns 1,928 shares of the pharmacy operator’s stock valued at $145,000 after buying an additional 939 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.